Skip to main content
SpringerLink
Log in

Substance Abuse and Depression

  • Chapter
Pharmacotherapy of Depression

  • 186 Accesses

Abstract

Depression, complicated by substance abuse, is a common clinical problem and is often associated with poor clinical outcomes. Clinicians need to understand the relationship between these two conditions and must adjust their treatment plans to address both disorders simultaneously. It is critical that the clinician not confuse a substance-induced mood disorder with an independent depressive disorder. Unfortunately, the relationship between substance abuse and depression is not well understood and relatively few well-controlled studies have been conducted to help guide the treatment of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Meyer RE. How to understand the relationship between psychopathology and addictive disorders: another example of the chicken and the egg. Psychopathology and Addictive Disorders. New York, NY: The Guilford Press; 1986.

    Google Scholar 

  2. Merikangas KR, Leckman JF, Prusoff BA, Pauls DL, Weissman MM. Familial transmission of depression and alcoholism. Arch Gen Psychiatry 1985; 42: 367 - 372.

    Article  PubMed  CAS  Google Scholar 

  3. Grove WM, Andreasen NC, Winokur G. Primary and secondary affective disorders: unipolar patients compared on family aggregation. Compr Psychiatry 1987; 28: 113 - 126.

    Article  PubMed  CAS  Google Scholar 

  4. Prescott CA, Aggen SH, Kendler KS. Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. Arch Gen Psychiatry 2000; 57: 803 - 811.

    Article  PubMed  CAS  Google Scholar 

  5. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 1989; 261: 403 - 407.

    Article  PubMed  CAS  Google Scholar 

  6. Glass IB, Jackson P. Maudsley Hospital Survey: prevalence of alcohol problems and other psychiatric disorders in a hospital population. Br J Addict 1988; 83: 1105 - 1111.

    Article  PubMed  CAS  Google Scholar 

  7. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys’ estimates. Arch Gen Psychiatry 2002; 59: 115 - 123.

    Article  PubMed  Google Scholar 

  8. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiological catchment area (ECA) study. JAMA 1990; 264: 2511 - 2518.

    Article  PubMed  CAS  Google Scholar 

  9. Kessler RC. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Study. Arch Gen Psychiatry 1994; 51: 8 - 19.

    Article  PubMed  CAS  Google Scholar 

  10. Bucholz KK. Nosology and epidemiology of addictive disorders and their comorbidity. Psychiatr Clin North Am 1999; 22: 221 - 240.

    Article  PubMed  CAS  Google Scholar 

  11. Gold MS, Miller NS, Hoffmann NG. Depression in drug dependency. Abstract presented at: American Psychiatric Association Convention, Philadelphia, PA; May 25, 1994;

    Google Scholar 

  12. Miller NS, Ninonuevo F, Hoffmann NG, Astrachan BM. Predictors of treatment outcome: lifetime depression versus continuum of care. American Journal of Addiction 1999; 8: 243 - 253.

    Article  CAS  Google Scholar 

  13. Hasin DS, Grant BF. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 2002; 59: 794 - 800.

    Article  PubMed  Google Scholar 

  14. Kirchner JE, Curran GM, Thrush CR, Owen RR, Fortney JC, Booth BM. Depressive disorders and alcohol dependence in a community population. Community Ment Health J 2002; 38: 361 - 373.

    Article  PubMed  Google Scholar 

  15. Devanand DP. Comorbid psychiatric disorders in late life depression. Biol Psychiatry 2002; 52: 236 - 242.

    Article  PubMed  CAS  Google Scholar 

  16. Compton WMr, Cottler LB, Ben Abdallah A, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. American Journal of Addiction 2000; 9: 113 - 125.

    Article  Google Scholar 

  17. Gamma A, Buck A, Berthold T, Vollenweider FX. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study. J Clin Psychopharmacol 2001; 21: 66 - 71.

    Article  PubMed  CAS  Google Scholar 

  18. MacInnes N, Handley SL, Harding GF. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol (Oxf) 2001; 15: 181 - 186.

    Article  CAS  Google Scholar 

  19. Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci 2000; 12: 480 - 484.

    Article  PubMed  CAS  Google Scholar 

  20. Fergusson DM, Lynskey MT, Horwood LJ. Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds. Arch Gen Psychiatry 1996; 53: 1043 - 1047.

    Article  PubMed  CAS  Google Scholar 

  21. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF. Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Adolesc Psychiatry 1996; 35: 1602 - 1610.

    Article  PubMed  CAS  Google Scholar 

  22. Dierker LC, Avenevoli S, Merikangas KR, Flaherty BP, Stolar M. Association between psychiatric disorders and the progression of tobacco use behaviors. J Am Acad Child Adolesc Psychiatry 2001; 40: 1159 - 1167.

    Article  PubMed  CAS  Google Scholar 

  23. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158: 2033 - 2037.

    Article  PubMed  CAS  Google Scholar 

  24. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002; 59: 1039 - 1044.

    Article  PubMed  Google Scholar 

  25. Chen CY, Wagner FA, Anthony JC. Marijuana use and the risk of Major Depressive Episode: epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 199 - 206.

    Article  PubMed  Google Scholar 

  26. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. Br Med J 2002; 325: 1195 - 1198.

    Article  Google Scholar 

  27. Vaillant GE. The Natural History of Alcoholism: Causes, Patterns and Pathways to Recovery. Cambridge, Mass: Harvard University Press; 1983.

    Google Scholar 

  28. McLellan AT, Luborsky L, Woody GE, O’Brien CP, Druley KA. Predicting response to alcohol and drug treatments: role of psychiatric severity. Arch Gen Psychiatry 1983; 40: 620 - 625.

    Article  PubMed  CAS  Google Scholar 

  29. McLellan AT, Luborsky L, O’Brien CP. Alcohol and drug abuse treatment in three different populations: is there improvement and is it predictable? Am J Drug Alcohol Abuse 1986; 12: 101 - 120.

    Article  PubMed  CAS  Google Scholar 

  30. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987; 44: 505 - 513.

    Article  PubMed  CAS  Google Scholar 

  31. Schaefer MR, Sobieraj K, Hollyfield RL. Severity of alcohol dependence and its relationship to additional psychiatric symptoms in male alcoholic inpatients. Am J Drug Alcohol Abuse 1987; 13: 435 - 447.

    Article  PubMed  CAS  Google Scholar 

  32. Powell BJ, Penick EC, Nickel EJ, et al. Outcomes of comorbid alcoholic men: a 1-year follow-up. Alcohol Clin Exp Res 1992; 16: 131 - 138.

    Article  PubMed  CAS  Google Scholar 

  33. Bjork JM, Dougherty DM, Moeller FG. Symptomatology of depression and anxiety in female “social drinkers. ” Am J Drug Alcohol Abuse 1999; 25: 173 - 182.

    Article  PubMed  CAS  Google Scholar 

  34. Mueller TI, Lavori PW, Keller MB, et al. Prognostic effect of the variable course of alcoholism on the 10-year course of depression. Am J Psychiatry 1994; 151: 701 - 706.

    PubMed  CAS  Google Scholar 

  35. Hasin DS, Tsai W-Y, Endicott J, Mueller TI, Coryell W, Keller M. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord 1996; 41: 63 - 70.

    Article  PubMed  CAS  Google Scholar 

  36. Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974; 125: 355 - 373.

    Article  PubMed  CAS  Google Scholar 

  37. Robins E. The Final Months: A Study of the Lives of 134 Who Committed Suicide. New York, NY: Oxford University Press; 1981.

    Google Scholar 

  38. Tondo L, Baldessarini RJ, Hennen J, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorder. J Clin Psychiatry 1999; 60 (Suppl 2):S63– S69; discussion 75-76, 113 - 116.

    Google Scholar 

  39. Grant BF, Hasin DS. Suicidal ideation among the United States drinking population: results from the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol 1999; 60: 422 - 429.

    PubMed  CAS  Google Scholar 

  40. Aharonovich E, Liu X, Nunes E, Hasin DS. Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry 2002; 159: 1600 - 1602.

    Article  PubMed  Google Scholar 

  41. Curran GM, Flynn HA, Kirchner J, Booth BM. Depression after alcohol treatment as a risk factor for relapse among male veterans. J Subst Abuse Treat 2000; 19: 259 - 265.

    Article  PubMed  CAS  Google Scholar 

  42. Hasin DS, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 2002; 59: 375 - 380.

    Article  PubMed  Google Scholar 

  43. Kahler CW, Ramsey SE, Read JP, Brown RA. Substance-induced and independent major depressive disorder in treatment-seeking alcoholics: associations with dysfunctional attitudes and coping. J Stud Alcohol 2002; 63: 363 - 371.

    PubMed  Google Scholar 

  44. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  45. Hesselbrock VM, Tennen H, Stabenau J, Hesselbrock M. Affective disorder in alcoholism. Int J Addict 1983; 18: 435 - 444.

    PubMed  CAS  Google Scholar 

  46. Jaffe JH, Ciraulo DA. Alcoholism and depression. In: Meyer RE, ed. Psychopathology and Addictive Disorders. New York, NY: Guilford Press; 1986: 293 - 320.

    Google Scholar 

  47. Ciraulo DA, Barnhill JG, Greenblatt DJ, et al. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 1988; 49: 333 - 337.

    PubMed  CAS  Google Scholar 

  48. Khantzian EJ. Psychopathology, psychodynamics, and alcoholism. In: Pattison EM, Kaufman E, eds. Encyclopedia Handbook of Alcoholism. New York, NY: Gardner; 1982: 581 - 597.

    Google Scholar 

  49. Behar D, Winokur G, Berg CJ. Depression in the abstinent alcoholic. Am J Psychiatry 1984; 141: 1105 - 1107.

    PubMed  CAS  Google Scholar 

  50. Beck AT. Depression Inventory. Philadelphia, Pa: Philadelphia Center for Cognitive Therapy; 1978.

    Google Scholar 

  51. Schuckit M. Alcoholic patients with secondary depression. Am J Psychiatry 1983; 140: 711 - 714.

    PubMed  CAS  Google Scholar 

  52. Merikangas KR, Gelernter CS. Comorbidity for alcoholism and depression. Psychiatr Clin North Am 1990; 13: 613 - 632.

    PubMed  CAS  Google Scholar 

  53. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988; 45: 1023 - 1031.

    Article  PubMed  CAS  Google Scholar 

  54. Abraham HD, Fava M. Order of onset of substance abuse and depression in a sample of depressed outpatients. Compr Psychiatry 1999; 40: 44 - 50.

    Article  PubMed  CAS  Google Scholar 

  55. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985; 42: 1050 - 1055.

    Article  PubMed  CAS  Google Scholar 

  56. Hen CW, Overall JE, Kaufman E. Predicting the post treatment depressive state of an alcoholic patient. Int J Addict 1990; 25: 1263 - 1273.

    Google Scholar 

  57. Kay DC. The search for psychopathic states in alcoholics and other drug abusers. In: Fann WE, Karacan I, Pokorny AD, Williams RL, eds. Phenomenology and Treatments of Alcoholism. New York, NY: Spectrum; 1980: 269 - 304.

    Chapter  Google Scholar 

  58. Ciraulo DA, Creelman WL, Shader RI, O’Sullivan R. Cyclic antidepressants. In: Ciraulo DA, Shader RI, Greenblatt DJ, Creelman WL, eds. Drug Interactions in Psychiatry. Baltimore, Md: Williams & Wilkins; 1995: 29 - 64.

    Google Scholar 

  59. Tanaka E. Toxicological interactions involving psychiatric drugs and alcohol: an update. J Clin Pharm Ther 2003; 28: 81 - 95.

    Article  PubMed  CAS  Google Scholar 

  60. Ciraulo DA, Shader RI, Greenblatt DJ. SSRI drug–drug interactions. In: Ciraulo DA, Shader RI, Greenblatt DJ, Creelman WL, eds. Drug interactions in psychiatry. Baltimore, Md: Williams & Wilkins; 1995: 64 - 90.

    Google Scholar 

  61. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47: 490 - 498.

    Article  PubMed  CAS  Google Scholar 

  62. Ciraulo DA, Barnhill JG, Jaffe JH. Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers. Clin Pharmacol Ther 1988; 43: 509 - 518.

    Article  PubMed  CAS  Google Scholar 

  63. Ciraulo DA, Barnhill JG, Jaffe AJ, Ciraulo AM, Tarmey MF. Intravenous pharmacokinetics of 2-hydroxyimipramine in alcoholics and normal controls. J Stud Alcohol 1990; 51: 366 - 372.

    PubMed  CAS  Google Scholar 

  64. Thase ME, Salloum IM, Corneliis JD. Comorbid alcoholism and depression: treatment issues. J Clin Psychiatry 2001; 63 (Suppl 20): S32–S41.

    Google Scholar 

  65. Mason BJ. Dosing issues in the pharmacotherapy of alcoholism. Alcohol Clin Exp Res 1996; 20 (Suppl 7): 10A–16A.

    Article  PubMed  CAS  Google Scholar 

  66. Ciraulo DA, Jaffe JH. Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharmacol 1981; 1: 146.

    Article  PubMed  CAS  Google Scholar 

  67. Mason BJ, Kocsis MD. Despiramine treatment of alcoholism. Psychopharmacol Bull 1991; 27: 155 - 161.

    PubMed  CAS  Google Scholar 

  68. Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 1993; 150: 963 - 965.

    PubMed  CAS  Google Scholar 

  69. McGrath PJ, Nunes EV, Stewart JW, et al. Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Arch Gen Psychiatry 1996; 53: 232 - 240.

    Article  PubMed  CAS  Google Scholar 

  70. Mason BJ, Kocsis MD, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996; 275: 803 - 804.

    Article  Google Scholar 

  71. Hyatt MC, Bird MA. Amitriptyline augments and prolongs ethanol-induced euphoria. J Clin Psychiatry 1987; 7: 277 - 278.

    CAS  Google Scholar 

  72. Lejoyeux M. Use of serotonin (5-hydroxytryptamiine) reuptake inhibitors in the treatment of alcoholism. Alcohol Alcohol 1996; 31 (Suppl 1): S69–S75.

    Article  Google Scholar 

  73. Sellers EM, Higgins GA. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. J Clin Psychiatry 1991; 52 (Suppl 12): S49–S54.

    Google Scholar 

  74. Leonard BE. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993; 54 (Suppl 8): S3–S5.

    Google Scholar 

  75. Loo H, Malka R, Defrance R, et al. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 1988; 19: 79 - 85.

    Article  PubMed  CAS  Google Scholar 

  76. Cornelius JR, Salloum IM, Cornelius MD, et al. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull 1993; 29: 195 - 199.

    PubMed  CAS  Google Scholar 

  77. Kranzler HR, Burleson JA, Korner P. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychol 1995; 152: 391 - 397.

    CAS  Google Scholar 

  78. Cornelius JR, Salloum IM, Ehler JG, et al. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54: 700 - 705.

    Article  PubMed  CAS  Google Scholar 

  79. Cornelius JR, Salloum IM, Thase ME, et al. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacol Bull 1998; 34: 117 - 121.

    PubMed  CAS  Google Scholar 

  80. Cornelius JR, Salloum IM, Haskett RF, et al. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict Behav 2000; 25: 307 - 310.

    Article  PubMed  CAS  Google Scholar 

  81. Cornelius JR, Bukstein OG, Birmaher B, et al. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial. Addict Behav 2001; 26: 735 - 739.

    Article  PubMed  CAS  Google Scholar 

  82. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. Fluoxetine in drug-dependent delinquents with major depression. J Child Adolesc Psychopharmacol 1997; 7: 87 - 95.

    Article  PubMed  CAS  Google Scholar 

  83. Roy A. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biol Psychiatry 1998; 44: 633 - 637.

    Article  PubMed  CAS  Google Scholar 

  84. Pettinati HM, Volpicelli JR, Luck G. Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol 2001; 21: 143 - 153.

    Article  PubMed  CAS  Google Scholar 

  85. Tiihonen J, Ryynanen OP, Kauhanen HP, Hakola HP, Salaspuro M. Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study. Pharmacopsychiatry 1996; 29: 27 - 29.

    Article  PubMed  CAS  Google Scholar 

  86. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 1992; 51: 729 - 739.

    Article  PubMed  CAS  Google Scholar 

  87. Balldin J, Berggren U, Engel J, Eriksson M, Hard E, Soderpalm B. Effect of citalopram on alcohol intake in heavy drinkers. Alcohol Clin Exp Res 1994; 18: 1133 - 1136.

    Article  PubMed  CAS  Google Scholar 

  88. Naranjo CA, Knoke DM, Bremner KE. Variations in response to citalopram in men and women with alcohol dependence. J Psychiatry Neurosci 2000; 25: 269 - 275.

    PubMed  CAS  Google Scholar 

  89. Nierenberg AA, Adler LA, Peselow E, Zornberg G, Rosenthal M. Trazodone for antidepressant-associated insomnia. Am J Psychiatry 1994; 151: 1069 - 1072.

    PubMed  CAS  Google Scholar 

  90. Le Bon O, Murphy JR, Staner L, et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 2003; 23: 377 - 383.

    Article  PubMed  CAS  Google Scholar 

  91. Pettinati HM. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J Clin Psychiatry 2001; 62 (Suppl 20): S26–S31.

    Google Scholar 

  92. Pettinati HM, Kranzler HR, Madaras J. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence. Recent Dev Alcohol 2003; 16: 247 - 262.

    Article  PubMed  Google Scholar 

  93. Johnson BA, DiClemente CC, Cloninger CR, et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients. JAMA 2000; 284: 963 - 971.

    Article  PubMed  CAS  Google Scholar 

  94. Lader MH. Tolerability and safety: essentials in antidepressant pharmacotherapy. 57 1996; 2.

    Google Scholar 

  95. Roy-Byrne PP, Pages KP, Russo JE, et al. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2000; 20: 129 - 136.

    Article  PubMed  CAS  Google Scholar 

  96. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995; 56: 19 - 24.

    PubMed  Google Scholar 

  97. Reich LH, Davies RK, Himmelhoch JM. Excessive alcohol use in manic depressive illness. Am J Psychiatry 1974; 131: 83 - 86.

    PubMed  CAS  Google Scholar 

  98. Brady KT, Sonne SC, Anton R, Ballenger JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 1995; 56: 118 - 121.

    PubMed  CAS  Google Scholar 

  99. Albanese MJ, Clodfelter RC, Jr., Khantzian EJ. Divalproex sodium in substance abusers with mood disorder. J Clin Psychiatry 2000; 61: 916 - 921.

    Article  PubMed  CAS  Google Scholar 

  100. Hertzman M. Divalproex sodium to treat concomitant substance abuse and mood disorders. J Subst Abuse Treat 2000; 18: 371 - 372.

    Article  PubMed  CAS  Google Scholar 

  101. Goldberg JF, Garno JL, Leon AC, Kocis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999; 60: 733 - 740.

    Article  PubMed  CAS  Google Scholar 

  102. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003; 361: 1677 - 1685.

    Article  PubMed  CAS  Google Scholar 

  103. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 1986; 43: 107 - 113.

    Article  PubMed  CAS  Google Scholar 

  104. Brower KJ, Maddahian E, Blow FC, Beresford TP. A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am J Drug Alcohol Abuse 1988; 14: 347 - 356.

    Article  PubMed  CAS  Google Scholar 

  105. Lowenstein DH, Massa SM, Rowbotham MC, Collins SD, McKinney HE, Simon RP. Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 1987; 83: 841 - 846.

    Article  PubMed  CAS  Google Scholar 

  106. Kleinman PH, Miller AB, Millman RB, et al. Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis 1990; 178: 442 - 447.

    Article  PubMed  CAS  Google Scholar 

  107. Brown RA, Monti PM, Myers MG, et al. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 1998; 155: 220 - 225.

    PubMed  CAS  Google Scholar 

  108. Gawin FH, Kleber HD, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117 - 121.

    Article  PubMed  CAS  Google Scholar 

  109. Weiss RD. Relapse to cocaine abuse after initiating desipramine treatment. JAMA 1988; 260: 2545 - 2546.

    Article  PubMed  CAS  Google Scholar 

  110. Ziedonis DM, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27: 337 - 343.

    PubMed  CAS  Google Scholar 

  111. Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend 1995; 39: 185 - 195.

    Article  PubMed  CAS  Google Scholar 

  112. Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend 2001; 63: 207 - 214.

    Article  PubMed  CAS  Google Scholar 

  113. McDowell DM, Levin FR, Seracini AM, Nunes EV. Venlafaxine treatment of cocaine abusers with depressive disorders. Am J Drug Alcohol Abuse 2000; 26: 25 - 31.

    Article  PubMed  CAS  Google Scholar 

  114. Lavori, PW, Bloch DA, Bridge PT, Leiderman DB, LoCastro JS, Somoza, E. Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDANA/ 50 Working Group on Design and Analysis. J Clin Psychiatry 1999; 19: 246 - 256.

    CAS  Google Scholar 

  115. 112b.Ciraulo DA, Rotrosen J, Leiderman D, Knapp C, Sarid-Segal O, Villagio E. Nefazodoneinduced alterations of cocaine craving and use in dysphoric cocaine users. Drug Alcohol Depend 2000; 60 Suppl 1: 538.

    Google Scholar 

  116. Gawin FH. New uses of antidepressants in cocaine abuse. Psychosomatics 1986; 27 (Suppl 11): S24–S29.

    Google Scholar 

  117. Meyer RE. New pharmacotherapies for cocaine dependence… revisited. Arch Gen Psychiatry 1992; 49: 900 - 904.

    Article  PubMed  CAS  Google Scholar 

  118. Lima MS, Reisser AA, Soares BG, Farrell M. Antidepressants for cocaine dependence. Cochrane Database Syst Review 2003; 2:CD002950.

    Google Scholar 

  119. Batki SL, Manfredi LB, Jacob P, III, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Psychopharmacol (Oxf) 1993; 13: 243 - 250.

    CAS  Google Scholar 

  120. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982; 39: 161 - 166.

    Article  PubMed  CAS  Google Scholar 

  121. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997; 54: 71 - 80.

    Article  PubMed  CAS  Google Scholar 

  122. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy of opiate addicts: does it help? Arch Gen Psychiatry 1983; 40: 639 - 645.

    Article  PubMed  CAS  Google Scholar 

  123. Woody GE, O’ Brien CP, Rickels K. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. Am J Psychiatry 1975; 132: 447 - 450.

    PubMed  CAS  Google Scholar 

  124. Titievsky J, Seco G, Barranco M, Kyle EM. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study. J Clin Psychiatry 1982; 43: 454 - 456.

    PubMed  CAS  Google Scholar 

  125. Kleber HD, Weissman MM, Rounsaville BJ, Wilber CH, Prusoff BA, Riordan CE. Imipramine as treatment for depression in addicts. Arch Gen Psychiatry 1983; 40: 649 - 653.

    Article  PubMed  CAS  Google Scholar 

  126. Nunes EV, Quitkin FM, Donovan SJ, et al. Imipramine treatment of opiate-dependent patients with depressive disorders: a placebo-controlled trial. Arch Gen Psychiatry 1998; 55: 153 - 160.

    Article  PubMed  CAS  Google Scholar 

  127. Maany I, Dhopesh V, Arndt IO, Burke W, Woody G, O’ Brien CP. Increase in desipramine serum levels associated with methadone maintenance. Am J Psychiatry 1989; 146: 1611 - 1613.

    PubMed  CAS  Google Scholar 

  128. Petrakis I, Carroll KM, Nich C, Gordon L, Kosten T, Rounsaville B. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug Alcohol Depend 1998; 50: 221 - 226.

    Article  PubMed  CAS  Google Scholar 

  129. Dean AJ, Bell J, Mascord DJ, Parker G, Christie MJ. A randomized, controlled trial of fluoxetine in methadone maintenance patients with depression. J Affect Disord 2002; 72: 85 - 90.

    Article  PubMed  CAS  Google Scholar 

  130. Hamilton SP, Nunes EV, Janai M, Weber L. The effect of sertraline on methadone plasma levels in methadone-maintained patients. American Journal of Addiction 2000; 9: 63 - 69.

    Article  CAS  Google Scholar 

  131. Woody GE, McLellan AT, Luborsky L, et al. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study. Am J Psychiatry 1984; 141: 1172 - 1177.

    PubMed  CAS  Google Scholar 

  132. Woody GE, McLellan AT, Luborsky L, O’ Brien CP. Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiatry 1987; 144: 590 - 596.

    PubMed  CAS  Google Scholar 

  133. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986; 43: 733 - 738.

    Article  PubMed  CAS  Google Scholar 

  134. Kanof PD, Aronson MJ, Ness R. Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry 1993; 150: 423 - 428.

    PubMed  CAS  Google Scholar 

  135. Keller MB. Long-term outcome of episodes of major depression. JAMA 1984; 252: 788 - 792.

    Article  PubMed  CAS  Google Scholar 

  136. Kofoed L, Kania J, Walsh T, Atkinson RM. Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders. Am J Psychiatry 1986; 143: 867 - 872.

    PubMed  CAS  Google Scholar 

  137. O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992; 49: 881 - 887.

    Article  PubMed  Google Scholar 

  138. Volpicelli JR, Alterman AI, Hayashida M, O’ Brien CP. Naltrexone in the treatment of alcohol-dependence. Arch Gen Psychiatry 1992; 49: 876 - 880.

    Article  PubMed  CAS  Google Scholar 

  139. McLellan AT, Alterman AI. Patient treatment matching: a conceptual and methodological review with suggestions for future research. In: Pickens RW, Leukefeld CG, Schuster CR, eds. Improving Drug Abuse Treatment. Rockville, Md: National Institute on Drug Abuse; 1991: 114 - 135.

    Google Scholar 

  140. Haertzen CA. Development of scales based on patterns of drug effects, using the addiction research center inventory. Psychol Rep 1966; 18: 163 - 194.

    Article  PubMed  CAS  Google Scholar 

  141. Sarid-Segal O, Knapp CM, Ciraulo AM, Greenblatt DJ, Shader RI, Ciraulo DA. Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism. J Clin Pharmacol 2000; 40: 84 - 90.

    Article  PubMed  CAS  Google Scholar 

  142. Akiskal HS. Cyclothymic temperamental disorders. Psychiatr Clin North Am 1979; 2 - 3.

    Google Scholar 

Download references

Authors
  1. John A. Renner Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey D. Baxter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Domenic A. Ciraulo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Psychiatry, Boston University School of Medicine, Boston, MA, USA

    Domenic A. Ciraulo MD

  2. Division of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA

    Richard I. Shader MD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Renner, J.A., Baxter, J.D., Ciraulo, D.A. (2004). Substance Abuse and Depression. In: Ciraulo, D.A., Shader, R.I. (eds) Pharmacotherapy of Depression. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-792-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-792-5_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6172-6

  • Online ISBN: 978-1-59259-792-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation